Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 14,636 shares at $138.60 ($2.0M) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($2.0M) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.65 | 853 | $114K | 5.6% |
| 2 | $135.70 | 369 | $50K | 2.5% |
| 3 | $137.56 | 599 | $82K | 4.1% |
| 4 | $138.60 | 421 | $58K | 2.9% |
| 5 | $138.60 | 5,176 | $717K | 35.3% |
| 6 | $139.49 | 435 |
| $61K |
| 3.0% |
| 7 | $139.49 | 5,350 | $746K | 36.8% |
| 8 | $140.59 | 1,433 | $201K | 9.9% |
| Total | $138.74 avg | 14,636 | $2.0M | 100% |
| Filing → |
| ALXN | SELL | 2017-01-09 | $2.0M | — | Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |